Announcement
Nature Biotechnology's October cover depicts engineered inhalable exosomes
Nature Biotechnology says the exosomes display a bispecific T cell activator targeting a cancer cell and a T cell.
TLDR
Nature Biotechnology announced its October 2026 issue with a cover depicting engineered inhalable exosomes. It says the exosomes display a bispecific T cell activator targeting a cancer cell and a T cell, while PD1 and FZD on the exosomes block tumor-cell PD-L1 signaling and neutralize tumor-secreted Wnt, respectively.
Combined views
8.7K
1 Source, first seen ago
